Factors Affecting the Synthesis of Bovine Serum Albumin Nanoparticles Using the Desolvation Method

References

• Kouchakzadeh H, Safavi MS, Shojaosadati SA. Efficient Delivery of Therapeutic Agents by Using Targeted Albumin Nanoparticles. 1st. Elsevier Inc.; 2015. doi:10.1016/bs.apcsb.2014.11.002
   Google Scholar
• Galisteo-González F, Molina-Bolívar JA. Systematic study on the preparation of BSA nanoparticles. Colloids Surf B Biointerfaces. 2014;123:286–292. doi:10.1016/j.colsurfb.2014.09.028
   PubMed Web of Science ®Google Scholar
• Dewi MK, Chaerunisaa AY, Muhaimin M, Joni IM. Improved Activity of Herbal Medicines through Nanotechnology. Nanomaterials. 2022;12(22):1–19. doi:10.3390/nano12224073
   Web of Science ®Google Scholar
• Tarhini M, Benlyamani I, Hamdani S, et al. Protein-based nanoparticle preparation via nanoprecipitation method. Materials (Basel). 2018;11(3):1–18. doi:10.3390/ma11030394
   Web of Science ®Google Scholar
• Loureiro A, Azoia G, Gomes A, Cavaco-Paulo A. Albumin-Based Nanodevices as Drug Carriers. Curr Pharm Des. 2016;22(10):1371–1390. doi:10.2174/1381612822666160125114900
   PubMed Web of Science ®Google Scholar
• Hong S, Choi DW, Kim HN, Park CG, Lee W, Park HH. Protein-based nanoparticles as drug delivery systems. Pharmaceutics. 2020;12(7):1–28. doi:10.3390/pharmaceutics12070604
   Web of Science ®Google Scholar
• Sethi A, Sher M, Akram MR, et al. Albumin as a drug delivery and diagnostic tool and its market approved products. Acta Pol Pharm - Drug Res. 2013;70(4):597–600.
   PubMed Web of Science ®Google Scholar
• Karami E, Behdani M, Kazemi-Lomedasht F. Albumin nanoparticles as nanocarriers for drug delivery: focusing on antibody and nanobody delivery and albumin-based drugs. J Drug Deliv Sci Technol. 2020;55:101471. doi:10.1016/j.jddst.2019.101471
   Web of Science ®Google Scholar
• Karimi M, Bahrami S, Ravari SB, et al. Albumin nanostructures as advanced drug delivery systems. Expert Opin Drug Delivery. 2017;13(11):1609–1623. doi:10.1080/17425247.2016.1193149
   Web of Science ®Google Scholar
• Tirkey B, Bhushan B, Uday Kumar S, Gopinath P. Prodrug encapsulated albumin nanoparticles as an alternative approach to manifest anti-proliferative effects of suicide gene therapy. Mater Sci Eng C. 2017;73:507–515. doi:10.1016/j.msec.2016.12.108
   PubMed Web of Science ®Google Scholar
• Elzoghby AO, Samy WM, Elgindy NA. Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release. 2012;157(2):168–182. doi:10.1016/j.jconrel.2011.07.031
   PubMed Web of Science ®Google Scholar
• Srivastava A, Prajapati A. Albumin and functionalized albumin nanoparticles: production strategies, characterization, and target indications. Asian Biomed. 2020;14(6):217–242. doi:10.1515/abm-2020-0032
   Web of Science ®Google Scholar
• An FF, Zhang XH. Strategies for preparing albumin-based nanoparticles for multifunctional bioimaging and drug delivery. Theranostics. 2017;7(15):3667–3689. doi:10.7150/thno.19365
   PubMed Web of Science ®Google Scholar
• Solanki R, Patel K, Patel S. Bovine Serum Albumin Nanoparticles for the Efficient Delivery of Berberine: preparation, Characterization and In vitro biological studies. Colloids Surf a Physicochem Eng Aspects. 2021;608:125501. doi:10.1016/j.colsurfa.2020.125501
   Web of Science ®Google Scholar
• Solanki R, Saini M, Mochi J, Pappachan A, Patel S. Synthesis, characterization, in-silico and in-vitro anticancer studies of Plumbagin encapsulated albumin nanoparticles for breast cancer treatment. J Drug Deliv Sci Technol. 2023;84:104501. doi:10.1016/j.jddst.2023.104501
   Web of Science ®Google Scholar
• Hornok V. Serum albumin nanoparticles: problems and prospects. Polymers. 2021;13(21):1–11. doi:10.3390/polym13213759
   Web of Science ®Google Scholar
• de Camargo LEA, Brustolin Ludwig D, Tominaga TT, et al. Bovine serum albumin nanoparticles improve the antitumour activity of curcumin in a murine melanoma model. J Microencapsul. 2018;35(5):467–474. doi:10.1080/02652048.2018.1526340
   PubMed Web of Science ®Google Scholar
• Matloubi Z, Hassan Z. HSA-curcumin nanoparticles: a promising substitution for Curcumin as a Cancer chemoprevention and therapy. DARU J Pharm Sci. 2020;28(1):209–219. doi:10.1007/s40199-020-00331-2
   Web of Science ®Google Scholar
• Bolaños K, Kogan MJ, Araya E. Capping gold nanoparticles with albumin to improve their biomedical properties. Int J Nanomed. 2019;14:6387–6406. doi:10.2147/IJN.S210992
   PubMed Web of Science ®Google Scholar
• Van de Sande L, Cosyns S, Willaert W, Ceelen W. Albumin-based cancer therapeutics for intraperitoneal drug delivery: a review. Drug Deliv. 2020;27(1):40–53. doi:10.1080/10717544.2019.1704945
   PubMed Web of Science ®Google Scholar
• Hoogenboezem EN, Duvall CL. Harnessing albumin as a carrier for cancer therapies. Adv Drug Deliv Rev. 2018;130:73–89. doi:10.1016/j.addr.2018.07.011
   PubMed Web of Science ®Google Scholar
• Kudarha RR, Sawant KK. Albumin based versatile multifunctional nanocarriers for cancer therapy: fabrication, surface modification, multimodal therapeutics and imaging approaches. Mater Sci Eng C. 2017;81:607–626. doi:10.1016/j.msec.2017.08.004
   PubMed Web of Science ®Google Scholar
• Zsila F. Subdomain IB is the third major drug binding region of human serum albumin: toward the three-sites model. Mol Pharm. 2013;10(5):1668–1682. doi:10.1021/mp400027q
   PubMed Web of Science ®Google Scholar
• Patel K, Jain P, Rajput PK, et al. Human serum albumin-based propulsive Piperlongumine-loaded nanoparticles: formulation development, characterization and anti-cancer study. Colloids Surf a Physicochem Eng Aspects. 2022;652:129738. doi:10.1016/j.colsurfa.2022.129738
   Web of Science ®Google Scholar
• Tao Yu H, Wang Qi R, Sheng W, Zhen Y. The development of human serum albumin-based drugs and relevant fusion proteins for cancer therapy. Int J Biol Macromol. 2021;187:24–34. doi:10.1016/j.ijbiomac.2021.07.080
   PubMed Web of Science ®Google Scholar
• Raoufinia R, Mota A, Keyhanvar N, Safari F, Shamekhi S, Abdolalizadeh J. Overview of albumin and its purification methods. Adv Pharm Bull. 2016;6(4):495–507. doi:10.15171/apb.2016.063
   PubMed Web of Science ®Google Scholar
• MacPhee CE, Woolfson DN. Engineered and designed peptide-based fibrous biomaterials. Curr Opin Solid State Mater Sci. 2004;8(2):141–149. doi:10.1016/j.cossms.2004.01.010
   Web of Science ®Google Scholar
• Solanki R, Rostamabadi H, Patel S, Jafari SM. Anticancer nano-delivery systems based on bovine serum albumin nanoparticles: a critical review. Int J Biol Macromol. 2021;193(PA):528–540. doi:10.1016/j.ijbiomac.2021.10.040
   PubMedGoogle Scholar
• Bhushan B, Khanadeev V, Khlebtsov B, Khlebtsov N, Gopinath P. Impact of albumin based approaches in nanomedicine: imaging, targeting and drug delivery. Adv Colloid Interface Sci. 2017;246:13–39. doi:10.1016/j.cis.2017.06.012
   PubMed Web of Science ®Google Scholar
• Wilson B, Ambika TV, Dharmesh Kumar Patel R, Jenita JL, Priyadarshini SRB. Nanoparticles based on albumin: preparation, characterization and the use for 5-flurouracil delivery. Int J Biol Macromol. 2012;51(5):874–878. doi:10.1016/j.ijbiomac.2012.07.014
   PubMed Web of Science ®Google Scholar
• Meng R, Zhu H, Wang Z, Hao S, Wang B. Preparation of Drug-Loaded Albumin Nanoparticles and Its Application in Cancer Therapy. J Nanomater. 2022;2022:1–12. doi:10.1155/2022/3052175
   Web of Science ®Google Scholar
• Solanki R, Patel S. Preparation, characterization and in vitro anticancer efficacy of biotin-conjugated, silibinin loaded bovine serum albumin nanoparticles. Food Biosci. 2023;56:103150. doi:10.1016/j.fbio.2023.103150
   Google Scholar
• Huang BX, Kim HY, Dass C. Probing three-dimensional structure of bovine serum albumin by chemical cross-linking and mass spectrometry. J Am Soc Mass Spectrom. 2004;15(8):1237–1247. doi:10.1016/j.jasms.2004.05.004
   PubMed Web of Science ®Google Scholar
• Sengupta P, Sardar PS, Roy P, Dasgupta S, Bose A. Investigation on the interaction of Rutin with serum albumins: insights from spectroscopic and molecular docking techniques. J Photochem Photobiol B: Biol. 2018;183:101–110. doi:10.1016/j.jphotobiol.2018.04.019
   PubMed Web of Science ®Google Scholar
• Lamichhane S, Lee S. Albumin nanoscience: homing nanotechnology enabling targeted drug delivery and therapy. Arch Pharm Res. 2020;43(1):118–133. doi:10.1007/s12272-020-01204-7
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen S, Yang X, Zhang S, Cui C. Preparation optimization of bovine serum albumin nanoparticles and its application for siRNA delivery. Drug Des Devel Ther. 2021;15:1531–1547. doi:10.2147/DDDT.S299479
   PubMed Web of Science ®Google Scholar
• Chang K, Liu J, Jiang W, Zhang R, Zhang T, Liu B. Ferulic acid-ovalbumin protein nanoparticles: structure and foaming behavior. Food Res Int. 2020;136:109311. doi:10.1016/j.foodres.2020.109311
   PubMed Web of Science ®Google Scholar
• Tazhbayev Y, Mukashev O, Burkeev M, Kreuter J. Hydroxyurea-loaded albumin nanoparticles: preparation, characterization, and in vitro studies. Pharmaceutics. 2019;11(8):8–16. doi:10.3390/pharmaceutics11080410
   Web of Science ®Google Scholar
• Bujacz A. Structures of bovine, equine and leporine serum albumin. Acta Crystallogr Sect D Biol Crystallogr. 2012;68(10):1278–1289. doi:10.1107/S0907444912027047
   PubMedGoogle Scholar
• Battogtokh G, Kang JH, Ko YT. Long-circulating self-assembled cholesteryl albumin nanoparticles enhance tumor accumulation of hydrophobic anticancer drug. Eur J Pharm Biopharm. 2015;96:96–105. doi:10.1016/j.ejpb.2015.07.013
   PubMed Web of Science ®Google Scholar
• Lee ES, Youn YS. Albumin-based potential drugs: focus on half-life extension and nanoparticle preparation. J Pharm Investig. 2016;46(4):305–315. doi:10.1007/s40005-016-0250-3
   Google Scholar
• Shimanovich U, Bernardes GJL, Knowles TPJ, Cavaco-Paulo A. Protein micro- and nano-capsules for biomedical applications. Chem Soc Rev. 2014;43(5):1361–1371. doi:10.1039/c3cs60376h
   PubMed Web of Science ®Google Scholar
• Anton N, Vandamme TF. The universality of low-energy nano-emulsification. Int J Pharm. 2009;377(1–2):142–147. doi:10.1016/j.ijpharm.2009.05.014
   PubMed Web of Science ®Google Scholar
• Safavi MS, Shojaosadati SA, Yang HG, et al. Reducing Agent-Free Synthesis of Curcumin-Loaded Albumin Nanoparticles by Self-Assembly at Room Temperature. Elsevier B.V; 2017. doi:10.1016/j.ijpharm.2017.06.087
   Google Scholar
• Nnyigide OS, Oh Y, Song HY, Park EK, Choi SH, Hyun K. Effect of urea on heat-induced gelation of bovine serum albumin (BSA) studied by rheology and small angle neutron scattering (SANS). Korea Aust Rheol J. 2017;29(2):101–113. doi:10.1007/s13367-017-0012-4
   Web of Science ®Google Scholar
• Hassanin I, Elzoghby A. Albumin-based nanoparticles: a promising strategy to overcome cancer drug resistance. Cancer Drug Resist. 2020. doi:10.20517/cdr.2020.68
   PubMedGoogle Scholar
• Yu X, Di Y, Xie C, et al. An in vitro and in vivo study of gemcitabine-loaded albumin nanoparticles in a pancreatic cancer cell line. Int J Nanomed. 2015;10(November):6825–6834. doi:10.2147/IJN.S93835
   PubMedGoogle Scholar
• Thao LQ, Byeon HJ, Lee C, et al. Pharmaceutical potential of tacrolimus-loaded albumin nanoparticles having targetability to rheumatoid arthritis tissues. Int J Pharm. 2016;497(1–2):268–276. doi:10.1016/j.ijpharm.2015.12.004
   PubMedGoogle Scholar
• Arpagaus C. PLA/PLGA nanoparticles prepared by nano spray drying. J Pharm Investig. 2019;49(4):405–426. doi:10.1007/s40005-019-00441-3
   Google Scholar
• Kimura K, Yamasaki K, Nishi K, Taguchi K, Otagiri M. Investigation of anti-tumor effect of doxorubicin-loaded human serum albumin nanoparticles prepared by a desolvation technique. Cancer Chemother Pharmacol. 2019;83:1113–1120. doi:10.1007/s00280-019-03832-3
   PubMed Web of Science ®Google Scholar
• Ziaaddini V, Saeidifar M, Eslami-Moghadam M, Saberi M, Mozafari M. Improvement of efficacy and decrement cytotoxicity of oxaliplatin anticancer drug using bovine serum albumin nanoparticles: synthesis, characterisation and release behaviour. IET Nanobiotechnol. 2020;14(1):105–111. doi:10.1049/iet-nbt.2019.0086
   PubMed Web of Science ®Google Scholar
• Tarhini M, Greige-Gerges H, Elaissari A. Protein-based nanoparticles: from preparation to encapsulation of active molecules. Int J Pharm. 2017;522(1–2):172–197. doi:10.1016/j.ijpharm.2017.01.067
   PubMed Web of Science ®Google Scholar
• Elzoghby AO, Elgohary MM, Kamel NM. Implications of Protein- and Peptide-Based Nanoparticles as Potential Vehicles for Anticancer Drugs. 1st. Elsevier Inc.; 2015. doi:10.1016/bs.apcsb.2014.12.002
   Google Scholar
• Joye IJ, McClements DJ. Production of nanoparticles by anti-solvent precipitation for use in food systems. Trends Food Sci Technol. 2013;34(2):109–123. doi:10.1016/j.tifs.2013.10.002
   Web of Science ®Google Scholar
• Rahimnejad M, Najafpour G, Bakeri G. Investigation and modeling effective parameters influencing the size of BSA protein nanoparticles as colloidal carrier. Colloids Surf a Physicochem Eng Aspects. 2012;412:96–100. doi:10.1016/j.colsurfa.2012.07.022
   Web of Science ®Google Scholar
• Tazhbayev Y, Mukashev O, Burkeyev M, Lozinsky VI. Synthesis and comparative study of nanoparticles derived from bovine and human serum albumins. Polymers. 2020;12(6):1301. doi:10.3390/polym12061301
   PubMed Web of Science ®Google Scholar
• Amighi F, Emam-djomeh Z, Labbafi-Mazraeh-Shahi M. Effect of different cross-linking agents on the preparation of bovine serum albumin nanoparticles. J Iran Chem Soc. 2020;17:1223–1235. doi:10.1007/s13738-019-01850-9
   Web of Science ®Google Scholar
• Wilson B, Paladugu L, Priyadarshini SRB, Jenita JJL. Development of albumin-based nanoparticles for the delivery of Abacavir. Int J Biol Macromol. 2015;81:763–767. doi:10.1016/j.ijbiomac.2015.09.015
   PubMed Web of Science ®Google Scholar
• Aljabali AAA, Bakshi HA, Hakkim FL, et al. Albumin nano-encapsulation of piceatannol enhances its anticancer potential in colon cancer via downregulation of nuclear p65 and HIF-1α. Cancers. 2020;12(1):113. doi:10.3390/cancers12010113
   PubMed Web of Science ®Google Scholar
• Díaz-Saldívar P, Huidobro-Toro JP. ATP-loaded biomimetic nanoparticles as controlled release system for extracellular drugs in cancer applications. Int J Nanomed. 2019;14:2433–2447. doi:10.2147/IJN.S192925
   PubMed Web of Science ®Google Scholar
• Noorani L, Pourgholami MH, Liang M, Morris DL, Stenzel M. Albendazole loaded albumin nanoparticles for ovarian cancer therapy. Eur J Nanomedicine. 2014;6(4):227–236. doi:10.1515/ejnm-2014-0026
   Google Scholar
• Kakran M, Sahoo NG, Li L, Judeh Z. Fabrication of quercetin nanoparticles by anti-solvent precipitation method for enhanced dissolution. Powder Technol. 2012;223:59–64. doi:10.1016/j.powtec.2011.08.021
   Web of Science ®Google Scholar
• Ganesh K, Archana D, Preeti K. Galactosylated albumin nanoparticles of simvastatin. Iran J Pharm Res. 2015;14(2):407–415.
   PubMed Web of Science ®Google Scholar
• Dalvi SV, Dave RN. Controlling particle size of a poorly water-soluble drug using ultrasound and stabilizers in antisolvent precipitation. Ind Eng Chem Res. 2009;48(16):7581–7593. doi:10.1021/ie900248f
   Web of Science ®Google Scholar
• Jenita JJL, Vijaya C, Wilson B. Design and Characterization of Bovine Serum Albumin Nanocarriers For Tenofovir by Modified Desolvation Method. J Pharm Res. 2012;5(9)4663–4667.
   Google Scholar
• Meer TA, Sawant KP, Amin PD. Liquid antisolvent precipitation process for solubility modulation of bicalutamide. Acta Pharm. 2011;61(4):435–445. doi:10.2478/v10007-011-0036-0
   PubMed Web of Science ®Google Scholar
• Olaitan V, Chaw CS. Desolvation conditions for production of sulfasalazine based albumin nanoparticles: physical properties. Pharm Front. 2019;1–15. doi:10.20900/pf20190006
   Google Scholar
• Yang Z, Zhang N, Ma T, Liu L, Zhao L, Xie H. Engineered bovine serum albumin-based nanoparticles with pH-sensitivity for doxorubicin delivery and controlled release. Drug Deliv. 2020;27(1):1156–1164. doi:10.1080/10717544.2020.1797243
   PubMed Web of Science ®Google Scholar
• Abd Ellah NH, Ahmed EA, Abd-ellatief RB, Ali MF, Zahran AM, Hetta HF. Metoclopramide nanoparticles modulate immune response in a diabetic rat model: association with regulatory T cells and proinflammatory cytokines. Int J Nanomed. 2019;14:2383–2395. doi:10.2147/IJN.S196842
   PubMed Web of Science ®Google Scholar
• Jenita J, Wilson B, Chocalingam V. Albumin nanoparticles coated with polysorbate 80 as a novel drug carrier for the delivery of antiretroviral drug-Efavirenz. Int J Pharm Investig. 2014;4(3):142. doi:10.4103/2230-973x.138348
   PubMedGoogle Scholar
• Spada A, Emami J, Sanaee F, et al. Albumin nanoparticles for the delivery of a novel inhibitor of β-tubulin polymerization. J Pharm Pharm Sci. 2021;24(5):344–362. doi:10.18433/jpps31877
   PubMedGoogle Scholar
• Jenita JL. Development, evaluation and targeting of stavudine loaded serum albumin polymer based nanocarriers to HIV reservoirs. Asian J Pharm Clin Res. 2019;12(5):363–370. doi:10.22159/ajpcr.2019.v12i5.33005
   Google Scholar
• Syed H, Sailaja AK. Preparation and characterization of nanoparticulate drug delivery system for naproxen sodium using various desolvating agents. Nano Biomed Eng. 2019;11(3):254–263. doi:10.5101/nbe.v11i3.p254-263
   Google Scholar
• Radwan SES, El-Kamel A, Zaki EI, Burgalassi S, Zucchetti E, El-Moslemany RM. Hyaluronic-coated albumin nanoparticles for the non-invasive delivery of apatinib in diabetic retinopathy. Int J Nanomed. 2021;16:4481–4494. doi:10.2147/IJN.S316564
   PubMed Web of Science ®Google Scholar
• Burns DB, Zydney AL. Effect of solution pH on protein transport through ultrafiltration membranes. Biotechnol Bioeng. 1999;64(1):27–37. doi:10.1002/(SICI)1097-0290(19990705)64:1<27::AID-BIT3>3.0.CO;2-E
   PubMed Web of Science ®Google Scholar
• Bronze-Uhle ES, Costa BC, Ximenes VF, Lisboa-Filho PN. Synthetic nanoparticles of bovine serum albumin with entrapped salicylic acid. Nanotechnol Sci Appl. 2017;10:11–21. doi:10.2147/NSA.S117018
   PubMed Web of Science ®Google Scholar
• Hemlata Gupta S, Tejavath KK, Tejavath KK. ROS-mediated apoptosis induced by BSA nanospheres encapsulated with fruit extract of Cucumis prophetarum in various human cancer cell lines. ACS Omega. 2021;6(15):10383–10395. doi:10.1021/acsomega.1c00755
   PubMed Web of Science ®Google Scholar
• Eisele K, Gropeanu RA, Zehendner CM, et al. Fine-tuning DNA/albumin polyelectrolyte interactions to produce the efficient transfection agent cBSA-147. Biomaterials. 2010;31(33):8789–8801. doi:10.1016/j.biomaterials.2010.07.088
   PubMed Web of Science ®Google Scholar
• Rohiwal SS, Satvekar RK, Tiwari AP, Raut AV, Kumbhar SG, Pawar SH. Investigating the influence of effective parameters on molecular characteristics of bovine serum albumin nanoparticles. Appl Surf Sci. 2015;334:157–164. doi:10.1016/j.apsusc.2014.08.170
   Web of Science ®Google Scholar
• Langer K, Balthasar S, Vogel V, Dinauer N, Von Briesen H, Schubert D. Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharm. 2003;257(1–2):169–180. doi:10.1016/S0378-5173(03)00134-0
   PubMed Web of Science ®Google Scholar
• Kakran M, Sahoo NG, Li L, et al. Fabrication of drug nanoparticles by evaporative precipitation of nanosuspension. Int J Pharm. 2010;383(1–2):285–292. doi:10.1016/j.ijpharm.2009.09.030
   PubMedGoogle Scholar
• Gebregeorgis A, Bhan C, Wilson O, Raghavan D. Characterization of Silver/Bovine Serum Albumin (Ag/BSA) nanoparticles structure: morphological, compositional, and interaction studies. J Colloid Interface Sci. 2013;389(1):31–41. doi:10.1016/j.jcis.2012.08.041
   PubMedGoogle Scholar
• Sozer SC, Egesoy TO, Basol M, Cakan-Akdogan G, Akdogan Y. A simple desolvation method for production of cationic albumin nanoparticles with improved drug loading and cell uptake. J Drug Deliv Sci Technol. 2020;60:101931. doi:10.1016/j.jddst.2020.101931
   Web of Science ®Google Scholar
• Horn D, Rieger J. Organic nanoparticles in the aqueous phase - Theory, experiment, and use. Angew Chem Int Educ. 2001;40(23):4330–4361. doi:10.1002/1521-3773(20011203)40:23
   PubMed Web of Science ®Google Scholar
• Quintanar-Guerrero D, Allémann E, Fessi H, Doelker E. Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind Pharm. 1998;24(12):1113–1128. doi:10.3109/03639049809108571
   PubMed Web of Science ®Google Scholar
• Stainmesse S, Orecchioni AM, Nakache E, Puisieux F, Fessi H. Formation and stabilization of a biodegradable polymeric colloidal suspension of nanoparticles. Colloid Polym Sci. 1995;273(5):505–511. doi:10.1007/BF00656896
   Web of Science ®Google Scholar
• Jahanshahi M, Babaei Z. Protein nanoparticle: a unique system as drug delivery vehicles. Afr J Biotechnol. 2008;7(25):4926–4934. doi:10.4314/ajb.v7i25.59701
   Web of Science ®Google Scholar
• Pal SL, Jana U, Manna PK, Mohanta GP, Manavalan R. Nanoparticle: an overview of preparation and characterization. J Appl Pharm Sci. 2011;1(6):228–234.
   Google Scholar
• Sadeghi R, Moosavi-Movahedi AA, Emam-Jomeh Z, et al. The effect of different desolvating agents on BSA nanoparticle properties and encapsulation of curcumin. J Nanopart Res. 2014;16(9). doi:10.1007/s11051-014-2565-1
   Web of Science ®Google Scholar
• Sailaja AK. A comparative study of aspirin loaded bovine serum albumin nanoparticles prepared by desolvation technique using various desolvating agents. Nano Biomed Eng. 2017;9(2):143–151. doi:10.5101/nbe.v9i2.p143-15
   Google Scholar
• Taheri A, Razavi SMA. Fabrication of cress seed gum nanoparticles, an anionic polysaccharide, using desolvation technique: an optimization study. Bionanoscience. 2015;5(2):104–116. doi:10.1007/s12668-015-0169-6
   Google Scholar
• Santos-Rebelo A, Kumar P, Pillay V, et al. Development and mechanistic insight into the enhanced cytotoxic potential of parvifloron D albumin nanoparticles in EGFR-overexpressing pancreatic cancer cells. Cancers. 2019;11(11). doi:10.3390/cancers11111733
   PubMed Web of Science ®Google Scholar
• Krishna Sailaja A, Nandini M. Effect of various desolvating agents in the formulation of naproxen loaded BSA nanoparticles. J Bionanoscience. 2017;11(6):497–503. doi:10.1166/jbns.2017.1472
   Google Scholar
• Arroyo-Maya IJ, Hernández-Sánchez H, Jiménez-Cruz E, Camarillo-Cadena M, Hernández-Arana A. α-Lactalbumin nanoparticles prepared by desolvation and cross-linking: structure and stability of the assembled protein. Biophys Chem. 2014;193–194:27–34. doi:10.1016/J.BPC.2014.07.003
   PubMed Web of Science ®Google Scholar
• Niknejad H, Mahmoudzadeh R. Comparison of different crosslinking methods for preparation of docetaxel-loaded albumin nanoparticles. Iran J Pharm Res. 2015;14(2):385–394.
   PubMed Web of Science ®Google Scholar
• Kim JY, Ahn JH, Song SB, et al. Enhancement of the Strength and Stability of Ultraviolet-Irradiated Acellular Dermal Matrix by Adding Glucose. Key Eng Mater. 2007;342–343:337–340. doi:10.4028/www.scientific.net/kem.342-343.337
   Google Scholar
• Ohan MP, Dunn MG. Glucose stabilizes collagen sterilized with gamma irradiation. J Biomed Mater Res - Part A. 2003;67(4):1188–1195. doi:10.1002/jbm.a.20018
   PubMedGoogle Scholar
• Suh H, Lee C. Biodegradable ceramic-collagen composite implanted in rabbit tibiae. ASAIO J. 1995;41(3):M652–M656. doi:10.1097/00002480-199507000-00091
   PubMedGoogle Scholar
• Weadock KS, Miller EJ, Bellincampi LD, Zawadsky JP, Dunn MG. Physical crosslinking of collagen fibers: comparison of ultraviolet irradiation and dehydrothermal treatment. J Biomed Mater Res. 1995;29(11):1373–1379. doi:10.1002/jbm.820291108
   PubMed Web of Science ®Google Scholar